Braicu C - Search Results

1

Pharmacokinetics Evaluation of Carbon Nanotubes Using FTIR Analysis and Histological Analysis.

Gherman C, Tudor MC, Constantin B, Flaviu T, Stefan R, Maria B, Chira S, Braicu C, Pop L, Petric RC, Berindan-Neagoe I. Gherman C, et al. Among authors: braicu c. J Nanosci Nanotechnol. 2015 Apr;15(4):2865-9. doi: 10.1166/jnn.2015.9845. J Nanosci Nanotechnol. 2015. PMID: 26353506

2

Early apoptosis signals induced by a low dose of epigallocatechin 3-gallate interfere with apoptotic and cell death pathways.

Berindan-Neagoe I, Braicu C, Tudoran O, Balacescu O, Irimie A. Berindan-Neagoe I, et al. Among authors: braicu c. J Nanosci Nanotechnol. 2012 Mar;12(3):2113-9. doi: 10.1166/jnn.2012.5701. J Nanosci Nanotechnol. 2012. PMID: 22755028

3

Epigallocatechin gallate induce cell death and apoptosis in triple negative breast cancer cells Hs578T.

Braicu C, Gherman C. Braicu C, et al. J Drug Target. 2013 Apr;21(3):250-256. doi: 10.3109/1061186X.2012.740673. Epub 2012 Nov 19. J Drug Target. 2013. PMID: 23163783

4

Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects.

Berindan-Neagoe I, Braicu C, Irimie A. Berindan-Neagoe I, et al. Among authors: braicu c. Int J Nanomedicine. 2012;7:6035-47. doi: 10.2147/IJN.S36523. Epub 2012 Dec 12. Int J Nanomedicine. 2012. PMID: 23251091 Free PMC article.

5

TNF-α gene knockout in triple negative breast cancer cell line induces apoptosis.

Pileczki V, Braicu C, Gherman CD, Berindan-Neagoe I. Pileczki V, et al. Among authors: braicu c. Int J Mol Sci. 2012 Dec 24;14(1):411-20. doi: 10.3390/ijms14010411. Int J Mol Sci. 2012. PMID: 23263670 Free PMC article.

6

Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells.

Braicu C, Gherman CD, Irimie A, Berindan-Neagoe I. Braicu C, et al. J Nanosci Nanotechnol. 2013 Jan;13(1):632-7. doi: 10.1166/jnn.2013.6882. J Nanosci Nanotechnol. 2013. PMID: 23646788

7

MicroRNAs and cancer therapy - from bystanders to major players.

Braicu C, Calin GA, Berindan-Neagoe I. Braicu C, et al. Curr Med Chem. 2013;20(29):3561-73. doi: 10.2174/0929867311320290002. Curr Med Chem. 2013. PMID: 23834177 Review.

8

Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?

Chiorean R, Braicu C, Berindan-Neagoe I. Chiorean R, et al. Among authors: braicu c. Breast. 2013 Dec;22(6):1026-33. doi: 10.1016/j.breast.2013.08.007. Epub 2013 Sep 21. Breast. 2013. PMID: 24063766 Free article. Review.

9

TIMP-1 expression in human colorectal cancer is associated with SMAD3 gene expression levels: a pilot study.

Ionescu C, Braicu C, Chiorean R, Cojocneanu Petric R, Neagoe E, Pop L, Chira S, Berindan-Neagoe I. Ionescu C, et al. Among authors: braicu c. J Gastrointestin Liver Dis. 2014 Dec;23(4):413-8. doi: 10.15403/jgld.2014.1121.234.smad. J Gastrointestin Liver Dis. 2014. PMID: 25532000 Free article.

10

Clinical and pathological implications of miRNA in bladder cancer.

Braicu C, Cojocneanu-Petric R, Chira S, Truta A, Floares A, Petrut B, Achimas-Cadariu P, Berindan-Neagoe I. Braicu C, et al. Int J Nanomedicine. 2015 Jan 20;10:791-800. doi: 10.2147/IJN.S72904. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25653521 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters